Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.036557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Yizhe Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Epidemiology, Spencer Fox-Eccles School of Medicine University of Utah Salt Lake City UT. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Practice Patterns, Physicians', Blood Pressure. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background Among patients diagnosed with high blood pressure (BP), initial dual therapy has been recommended for patients with high pretreatment systolic BP (≥160 mm Hg) since 2003, and first‐line β‐blocker use without a compelling condition has fallen out of favor in US guidelines. Methods and Results This serial cross‐sectional study of national Veterans Health Administration data included adult Veterans with incident hypertension initiating antihypertensive medication between January 1, 2000, and December 31, 2019. We assessed annual trends in initial regimens dispensed (index date: first antihypertensive dispense date) by number of classes and unique class combinations used overall and by pretreatment systolic BP (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Epidemiology, Spencer Fox-Eccles School of Medicine University of Utah Salt Lake City UT.
- Intermountain Healthcare Department of Population Health Sciences, Divisions of Health System Innovation and Research and Biostatistics, Spencer Fox-Eccles School of Medicine University of Utah Salt Lake City UT.
- George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City UT.
- Department of Research and Evaluation Kaiser Permanente Southern California Pasadena CA.
- Department of Preventive Medicine University of Tennessee Health Science Center Memphis TN.
- Division of Cardiology University of Colorado Anschutz Medical Campus Aurora CO.
ORCID-Profile: Yizhe Xu, Catherine G Derington, Daniel K Addo, Joshua A Jacobs, April F Mohanty, Jaejin An, William C Cushman, P Michael Ho, Brandon K Bellows, Jordana B Cohen, Adam P Bress
Förderung
- NIA NIH HHS
- NCATS NIH HHS
Zitieren
APA
Xu, Y., Derington, C. G., Addo, D. K., He, T., Jacobs, J. A., Mohanty, A. F., An, J., Cushman, W. C., Ho, P. M., Bellows, B. K., Cohen, J. B., & Bress, A. P. (2024). Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036557
Vancouver
Xu Y, Derington CG, Addo DK, He T, Jacobs JA, Mohanty AF, et al. Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.036557
BibTeX
@article{Xu2024,
author = {Xu, Yizhe and Derington, Catherine G and Addo, Daniel K and He, Tao and Jacobs, Joshua A and Mohanty, April F and An, Jaejin and Cushman, William C and Ho, P Michael and Bellows, Brandon K and Cohen, Jordana B and Bress, Adam P},
title = {Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.036557}
}
EUVIMED